Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Monday Oct 28, 2024
Monday Oct 28, 2024
touchCONGRESS for touchHAEMATOLOGY
Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joined by fellow experts, Prof. Susanne Saussele and Dr Carla Boquimpani, to consider the implications of these data for current and future clinical practice.
Overview
- Data reviews with Prof. Rosti
- Expert panel discussions with Prof. Susanne Saussele and Dr Carla Boquimpani on the themes below
Clinical themes
- Approved and emerging TKIs for CML in the first-line setting
- Approved and emerging TKIs for CML in the second- and later-line settings
- Potential impact of emerging data on current and future clinical practice
The internationally renowned multiple myeloma expert faculty
- Prof. Gianantonio Rosti: Meldola, Italy
- Prof. Susanne Saussele: Mannheim, Germany
- Dr Carla Boquimpani: Rio de Janeiro, Brazil
This touchPODCAST is for HCPs globally with the exclusion of the USA, the UK and Japan.
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: TBC
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.